If not administered properly, the GLP-1 medication can cause nausea, abdominal pain, and cramps, possibly leading to dehydration. The doses are normally taken a week apart, so not waiting long enough ...
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...
The weight of being a Hollywood star can take a toll on a person’s weight.In an industry obsessed with physical appearance, a ...
An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...
Recent reports link weight loss drugs Ozempic and Mounjaro to severe vision loss. With cases of blindness emerging, medical ...
After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.
A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...
Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.
However, weight loss is a sensitive topic and a personal choice. If you wish to talk to your friend or family member about it, taking a mindful approach can help you get your message across ...
Experts warn Ozempic and Mounjaro may cause sudden, irreversible blindness as patients report vision loss after taking the weight loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results